SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop shares are receiving significant attention following a series of insider purchases by board members and CEO Ryan Cohen, with retail investors expressing optimism that these moves signal internal confidence and potential future share buybacks. Sentiment remains highly bullish as traders speculate on further developments, with many highlighting the contrast between these purchases and the company's recent earnings report.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The conversation is dominated by concerns over escalating Middle East tensions and surging oil prices, which have triggered fears of persistent inflation and an potential interest rate hike. Traders are also debating the market's resilience in the face of these macroeconomic pressures ahead of upcoming CPI data.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to significant retail bullishness driven by the escalating conflict between the U.S. and Iran, which has disrupted Middle East shipping routes and raised fears of global oil supply constraints. Traders are closely monitoring the impact of pipeline attacks and shipping chokepoints on energy prices, with many anticipating continued upside despite concerns about potential government interventions or future ceasefires.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are receiving attention following a fiscal first-quarter earnings beat driven by triple-digit growth in cloud infrastructure and record AI contract bookings. While some traders express optimism regarding the company's AI-driven backlog and future growth prospects, others remain cautious, highlighting concerns over heavy capital expenditure, high debt levels, and overall macroeconomic headwinds.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending due to mixed reactions regarding the company's unexpected announcement of a new CEO, Anil Chakravarthy, and the accompanying departure of a key executive, overshadowing the anticipation of its upcoming earnings report. While some investors view the leadership transition as a stabilizing move for enterprise strategy, others remain skeptical, citing concerns over potential internal friction and the company's competitive positioning in an AI-driven market.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

BWET is trending due to its extreme performance driven by soaring crude-oil tanker freight rates, which have surged as geopolitical tensions and conflict in the Strait of Hormuz disrupt global shipping capacity. Traders are debating the sustainability of this parabolic rally, with many closely monitoring developments in the Middle East as the primary catalyst for further volatility.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as traders speculate on the company's progress toward its upcoming BLA submission and its potential for an eventual acquisition. While some investors remain bullish on the clinical pipeline and recent board appointments, others are expressing concern over insider selling and the risk of further share dilution.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders closely monitor rising long-term Treasury yields and aggressive selling, fueled by concerns over federal debt, persistent inflation, and Middle East tensions. Market participants are debating whether Treasury Secretary Bessent's efforts to stabilize the bond market through buybacks will prove effective or if rising rates will continue to pressure the asset toward all-time lows.

Frequency Electronics, Inc. engages in the design, development, and manufacture of precision time and frequency generation technology. It operates through the following business segments: FEI-NY and FEI-Zyfer. The FEI-NY segment provides precision time, frequency generation, and synchronization products and subsystems that are found on-board satellites, in ground-based communication stations, and imbedded in moving platforms. The FEI-Zyfer segment designs, develops, and manufactures products for precision time and frequency generation and synchronization, primarily incorporating GPS technology. The company was founded by Martin B. Bloch on August 25, 1961 and is headquartered in Uniondale, NY.

Frequency Electronics, Inc.

Frequency Electronics is seeing strong community interest following strong financial results, with traders highlighting record backlog growth and the company's critical role in next-generation aerospace, satellite, and defense technology.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Investors are expressing frustration as the stock continues to experience high volatility and a trend of intraday price reversals, despite reporting positive quarterly earnings. The conversation remains dominated by conflicting sentiments: bulls point to potential long-term value in the company's AI lending platform and upcoming bank charter, while bears focus on macro-economic headwinds, rising interest rates, and concerns over high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OTLK Q3 Earnings Call Maps LYTENAVA U.S. Launch and Sales Ramp

Outlook Therapeutics targets a year-end 2026 U.S. LYTENAVA launch, with $50M-$75M in first-year net revenues and a ramp tied to reimbursement.

Transcript: Outlook Therapeutics Q3 2026 Earnings Conference Call

Outlook Therapeutics (NASDAQ:OTLK) released third-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below.
This transcript is brought to you by Benzinga APIs. For real-timeread more...

Outlook Therapeutics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates

Outlook Therapeutics, Inc. (OTLK) delivered earnings and revenue surprises of 0.00% and -99.25%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Outlook Therapeutics Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Outlook Therapeutics (NASDAQ: OTLK) to release Q3 earnings on Aug. 14. Analysts expect a loss of 8 cents/share. Analysts rate it Neutral or Buy.read more...

Zealand Pharma A/S (ZLDPF) Surpasses Q2 Earnings and Revenue Estimates

Zealand Pharma AS (ZLDPF) delivered earnings and revenue surprises of +2,150.00% and +756.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Did OTLK Stock Crash In Pre-Market Today?

Equity

Outlook Therapeutics is looking to sell about 55.6 million common shares, accompanied by warrants, at a 10% discount over the stock’s closing price on Wednesday.

OTLK Up More Than 300% in 3 Months: Here's What You Should Know

Outlook Therapeutics rallies 311.8% in three months as Lytenava's FDA approval boosts optimism ahead of its planned U.S. launch by year-end.

iRhythm Holdings, Inc. (IRTC) Tops Q2 Earnings and Revenue Estimates

IRHYTHM HLDGS (IRTC) delivered earnings and revenue surprises of +5,900.00% and +2.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Outlook Therapeutics, Inc. (OTLK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Outlook Therapeutics, Inc. (OTLK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Outlook Therapeutics to Report Q3 Earnings: What's in the Cards?

OTLK heads into Q3 results with investors watching European Lytenava sales, U.S. launch plans and updates after its landmark FDA approval.

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

• Reported GAAP EPS of -$0.15 up 72.73% YoY
• Reported revenue of $0.01M down -99.40% YoY

Outlook Therapeutics reported a significant year-over-year revenue decline to $9 thousand, a persistent net loss of $20.3 million, and exposure to unpredictable macroeconomic risks and ongoing global conflicts for Outlook Therapeutics.

Outlook Therapeutics achieved FDA approval for LYTENAVA, which the company expects will drive a significant market opportunity with potential for over $500 million in annual U.S. sales by 2030 for Outlook Therapeutics.

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Outlook Therapeutics Inc

Extremely Bearish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Feed

News

Sentiment

Earnings

Fundamentals

Info

OTLK Outlook Therapeutics Inc

Fundamentals

Latest OTLK News